ID   IMDH2_BOVIN             Reviewed;         514 AA.
AC   Q3SWY3;
DT   13-JUN-2006, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 1.
DT   02-DEC-2020, entry version 110.
DE   RecName: Full=Inosine-5'-monophosphate dehydrogenase 2 {ECO:0000255|HAMAP-Rule:MF_03156};
DE            Short=IMP dehydrogenase 2 {ECO:0000255|HAMAP-Rule:MF_03156};
DE            Short=IMPD 2 {ECO:0000255|HAMAP-Rule:MF_03156};
DE            Short=IMPDH 2 {ECO:0000255|HAMAP-Rule:MF_03156};
DE            EC=1.1.1.205 {ECO:0000255|HAMAP-Rule:MF_03156};
DE   AltName: Full=IMPDH-II;
GN   Name=IMPDH2 {ECO:0000255|HAMAP-Rule:MF_03156};
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Ascending colon;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Catalyzes the conversion of inosine 5'-phosphate (IMP) to
CC       xanthosine 5'-phosphate (XMP), the first committed and rate-limiting
CC       step in the de novo synthesis of guanine nucleotides, and therefore
CC       plays an important role in the regulation of cell growth. Could also
CC       have a single-stranded nucleic acid-binding activity and could play a
CC       role in RNA and/or DNA metabolism. It may also have a role in the
CC       development of malignancy and the growth progression of some tumors.
CC       {ECO:0000255|HAMAP-Rule:MF_03156}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + IMP + NAD(+) = H(+) + NADH + XMP; Xref=Rhea:RHEA:11708,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57464,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:58053;
CC         EC=1.1.1.205; Evidence={ECO:0000255|HAMAP-Rule:MF_03156};
CC   -!- COFACTOR:
CC       Name=K(+); Xref=ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03156};
CC   -!- ACTIVITY REGULATION: Mycophenolic acid (MPA) is a non-competitive
CC       inhibitor that prevents formation of the closed enzyme conformation by
CC       binding to the same site as the amobile flap. In contrast, mizoribine
CC       monophosphate (MZP) is a competitive inhibitor that induces the closed
CC       conformation. MPA is a potent inhibitor of mammalian IMPDHs but a poor
CC       inhibitor of the bacterial enzymes. MZP is a more potent inhibitor of
CC       bacterial IMPDH. {ECO:0000255|HAMAP-Rule:MF_03156}.
CC   -!- PATHWAY: Purine metabolism; XMP biosynthesis via de novo pathway; XMP
CC       from IMP: step 1/1. {ECO:0000255|HAMAP-Rule:MF_03156}.
CC   -!- SUBUNIT: Homotetramer. Interacts with CLOCK; in a circadian manner (By
CC       similarity). {ECO:0000250|UniProtKB:P12268, ECO:0000255|HAMAP-
CC       Rule:MF_03156}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03156}.
CC       Nucleus {ECO:0000255|HAMAP-Rule:MF_03156}.
CC   -!- PTM: Acetylated by CLOCK in a circadian manner.
CC       {ECO:0000250|UniProtKB:P12268}.
CC   -!- SIMILARITY: Belongs to the IMPDH/GMPR family. {ECO:0000255|HAMAP-
CC       Rule:MF_03156}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC104602; AAI04603.1; -; mRNA.
DR   RefSeq; NP_001029588.1; NM_001034416.1.
DR   SMR; Q3SWY3; -.
DR   STRING; 9913.ENSBTAP00000025179; -.
DR   PaxDb; Q3SWY3; -.
DR   PeptideAtlas; Q3SWY3; -.
DR   PRIDE; Q3SWY3; -.
DR   Ensembl; ENSBTAT00000025179; ENSBTAP00000025179; ENSBTAG00000031837.
DR   GeneID; 511969; -.
DR   KEGG; bta:511969; -.
DR   CTD; 3615; -.
DR   VGNC; VGNC:30189; IMPDH2.
DR   eggNOG; KOG2550; Eukaryota.
DR   GeneTree; ENSGT00940000157726; -.
DR   HOGENOM; CLU_022552_2_1_1; -.
DR   InParanoid; Q3SWY3; -.
DR   OMA; HDYHMTL; -.
DR   OrthoDB; 618077at2759; -.
DR   TreeFam; TF300378; -.
DR   Reactome; R-BTA-6798695; Neutrophil degranulation.
DR   Reactome; R-BTA-73817; Purine ribonucleoside monophosphate biosynthesis.
DR   UniPathway; UPA00601; UER00295.
DR   Proteomes; UP000009136; Chromosome 22.
DR   Bgee; ENSBTAG00000031837; Expressed in conceptus and 18 other tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003938; F:IMP dehydrogenase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0000166; F:nucleotide binding; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:0007623; P:circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006177; P:GMP biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0006183; P:GTP biosynthetic process; IBA:GO_Central.
DR   GO; GO:0046651; P:lymphocyte proliferation; IEA:Ensembl.
DR   CDD; cd00381; IMPDH; 1.
DR   Gene3D; 3.20.20.70; -; 2.
DR   HAMAP; MF_01964; IMPDH; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR000644; CBS_dom.
DR   InterPro; IPR005990; IMP_DH.
DR   InterPro; IPR015875; IMP_DH/GMP_Rdtase_CS.
DR   InterPro; IPR001093; IMP_DH_GMPRt.
DR   Pfam; PF00571; CBS; 2.
DR   Pfam; PF00478; IMPDH; 1.
DR   PIRSF; PIRSF000130; IMPDH; 1.
DR   SMART; SM00116; CBS; 2.
DR   TIGRFAMs; TIGR01302; IMP_dehydrog; 1.
DR   PROSITE; PS51371; CBS; 2.
DR   PROSITE; PS00487; IMP_DH_GMP_RED; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; CBS domain; Cytoplasm; DNA-binding; GMP biosynthesis;
KW   Isopeptide bond; Metal-binding; NAD; Nucleus; Oxidoreductase;
KW   Phosphoprotein; Potassium; Purine biosynthesis; Reference proteome; Repeat;
KW   RNA-binding; Ubl conjugation.
FT   CHAIN           1..514
FT                   /note="Inosine-5'-monophosphate dehydrogenase 2"
FT                   /id="PRO_0000239736"
FT   DOMAIN          114..173
FT                   /note="CBS 1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   DOMAIN          179..237
FT                   /note="CBS 2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   NP_BIND         274..276
FT                   /note="NAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   NP_BIND         324..326
FT                   /note="NAD"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   REGION          364..366
FT                   /note="IMP binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   REGION          387..388
FT                   /note="IMP binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   REGION          411..415
FT                   /note="IMP binding"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   ACT_SITE        331
FT                   /note="Thioimidate intermediate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   ACT_SITE        429
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   METAL           326
FT                   /note="Potassium; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   METAL           328
FT                   /note="Potassium; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   METAL           331
FT                   /note="Potassium; via carbonyl oxygen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   METAL           500
FT                   /note="Potassium; via carbonyl oxygen; shared with
FT                   tetrameric partner"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   METAL           501
FT                   /note="Potassium; via carbonyl oxygen; shared with
FT                   tetrameric partner"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   METAL           502
FT                   /note="Potassium; via carbonyl oxygen; shared with
FT                   tetrameric partner"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   BINDING         329
FT                   /note="IMP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   BINDING         441
FT                   /note="IMP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03156"
FT   MOD_RES         122
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P12268"
FT   MOD_RES         160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P12268"
FT   MOD_RES         400
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P12268"
FT   MOD_RES         416
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P12268"
FT   MOD_RES         511
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P12268"
FT   CROSSLNK        195
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P12268"
FT   CROSSLNK        208
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P12268"
FT   CROSSLNK        438
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P12268"
SQ   SEQUENCE   514 AA;  55763 MW;  C41BB20F7FB604BA CRC64;
     MADYLISGGT SYVPDDGLTA QQLFNCGDGL TYNDFLILPG YIDFTADQVD LTSALTKKIT
     LKTPLVSSPM DTVTEAGMAI AMALTGGIGF IHHNCTPEFQ ANEVRKVKKY EQGFITDPVV
     LSPRDRVRDV FEAKARHGFC GIPITDTGRM GSHLVGIISS RDIDFLKEEE HDRLLGEIMT
     KREDLVVAPA GITLKEANEI LQRSKKGKLP IVNENDELVA IIARTDLKKN RDYPLASKDA
     KKQLLCGAAI GTHEDDKYRL DLLSQAGVDV VVLDSSQGNS IFQINMIKYI KEKYPSIQVI
     GGNVVTAAQA KNLIDAGVDA LRVGMGSGSI CITQEVLACG RPQATAVYKV SEYARRFGVP
     VIADGGIQNV GHIAKALALG ASTVMMGSLL AATTEAPGEY FFSDGIRLKK YRGMGSLDAM
     DKHLSSQNRY FSEADKIKVA QGVSGAVQDK GSIHKFVPYL IAGIQHSCQD IGAKSLTQVR
     AMMYSGELKF EKRTSSAQVE GGVHSLHSYE KRLF
//
